These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 30426066)
1. Derivation of cutoffs for the Elecsys Shaw LM; Waligorska T; Fields L; Korecka M; Figurski M; Trojanowski JQ; Eichenlaub U; Wahl S; Quan M; Pontecorvo MJ; Lachno DR; Talbot JA; Andersen SW; Siemers ER; Dean RA Alzheimers Dement (Amst); 2018; 10():698-705. PubMed ID: 30426066 [TBL] [Abstract][Full Text] [Related]
2. CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts. Hansson O; Seibyl J; Stomrud E; Zetterberg H; Trojanowski JQ; Bittner T; Lifke V; Corradini V; Eichenlaub U; Batrla R; Buck K; Zink K; Rabe C; Blennow K; Shaw LM; ; Alzheimers Dement; 2018 Nov; 14(11):1470-1481. PubMed ID: 29499171 [TBL] [Abstract][Full Text] [Related]
3. Alzheimer's cerebrospinal biomarkers from Lumipulse fully automated immunoassay: concordance with amyloid-beta PET and manual immunoassay in Koreans : CSF AD biomarkers measured by Lumipulse in Koreans. Moon S; Kim S; Mankhong S; Choi SH; Vandijck M; Kostanjevecki V; Jeong JH; Yoon SJ; Park KW; Kim EJ; Yoon B; Kim HJ; Jang JW; Hong JY; Park DH; Shaw LM; Kang JH Alzheimers Res Ther; 2021 Jan; 13(1):22. PubMed ID: 33436035 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of Elecsys immunoassays for cerebrospinal fluid Alzheimer's disease biomarkers in a nonacademic, multicenter memory clinic cohort: The ABIDE project. Willemse EAJ; van Maurik IS; Tijms BM; Bouwman FH; Franke A; Hubeek I; Boelaarts L; Claus JJ; Korf ESC; van Marum RJ; Roks G; Schoonenboom N; Verwey N; Zwan MD; Wahl S; van der Flier WM; Teunissen CE Alzheimers Dement (Amst); 2018; 10():563-572. PubMed ID: 30406175 [TBL] [Abstract][Full Text] [Related]
5. Comparing CSF amyloid-beta biomarker ratios for two automated immunoassays, Elecsys and Lumipulse, with amyloid PET status. Willemse EAJ; Tijms BM; van Berckel BNM; Le Bastard N; van der Flier WM; Scheltens P; Teunissen CE Alzheimers Dement (Amst); 2021; 13(1):e12182. PubMed ID: 33969174 [TBL] [Abstract][Full Text] [Related]
11. Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging. Schindler SE; Gray JD; Gordon BA; Xiong C; Batrla-Utermann R; Quan M; Wahl S; Benzinger TLS; Holtzman DM; Morris JC; Fagan AM Alzheimers Dement; 2018 Nov; 14(11):1460-1469. PubMed ID: 29501462 [TBL] [Abstract][Full Text] [Related]
12. Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid β-amyloid 42: a cross-validation study against amyloid positron emission tomography. Palmqvist S; Zetterberg H; Blennow K; Vestberg S; Andreasson U; Brooks DJ; Owenius R; Hägerström D; Wollmer P; Minthon L; Hansson O JAMA Neurol; 2014 Oct; 71(10):1282-9. PubMed ID: 25155658 [TBL] [Abstract][Full Text] [Related]
13. Analysis of Cerebrospinal Fluid and [11C]PIB PET Biomarkers for Alzheimer's Disease with Updated Protocols. Wang MJ; Yi S; Han JY; Park SY; Jang JW; Chun IK; Giau VV; Bagyinszky E; Lim KT; Kang SM; An SS; Park YH; Youn YC; Kim S J Alzheimers Dis; 2016 May; 52(4):1403-13. PubMed ID: 27163824 [TBL] [Abstract][Full Text] [Related]
15. Concordance and Diagnostic Accuracy of [11C]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease. Leuzy A; Carter SF; Chiotis K; Almkvist O; Wall A; Nordberg A J Alzheimers Dis; 2015; 45(4):1077-88. PubMed ID: 25649653 [TBL] [Abstract][Full Text] [Related]
16. Nonlinear Association Between Cerebrospinal Fluid and Florbetapir F-18 β-Amyloid Measures Across the Spectrum of Alzheimer Disease. Toledo JB; Bjerke M; Da X; Landau SM; Foster NL; Jagust W; Jack C; Weiner M; Davatzikos C; Shaw LM; Trojanowski JQ; JAMA Neurol; 2015 May; 72(5):571-81. PubMed ID: 25822737 [TBL] [Abstract][Full Text] [Related]
17. Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment. Janelidze S; Pannee J; Mikulskis A; Chiao P; Zetterberg H; Blennow K; Hansson O JAMA Neurol; 2017 Dec; 74(12):1492-1501. PubMed ID: 29114726 [TBL] [Abstract][Full Text] [Related]
18. Elecsys Lifke V; Kollmorgen G; Manuilova E; Oelschlaegel T; Hillringhaus L; Widmann M; von Arnim CAF; Otto M; Christenson RH; Powers JL; Shaw LM; Hansson O; Doecke JD; Li QX; Teunissen C; Tumani H; Blennow K Clin Biochem; 2019 Oct; 72():30-38. PubMed ID: 31129184 [TBL] [Abstract][Full Text] [Related]
19. Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1-42) in human cerebrospinal fluid. Bittner T; Zetterberg H; Teunissen CE; Ostlund RE; Militello M; Andreasson U; Hubeek I; Gibson D; Chu DC; Eichenlaub U; Heiss P; Kobold U; Leinenbach A; Madin K; Manuilova E; Rabe C; Blennow K Alzheimers Dement; 2016 May; 12(5):517-26. PubMed ID: 26555316 [TBL] [Abstract][Full Text] [Related]
20. Independent information from cerebrospinal fluid amyloid-β and florbetapir imaging in Alzheimer's disease. Mattsson N; Insel PS; Donohue M; Landau S; Jagust WJ; Shaw LM; Trojanowski JQ; Zetterberg H; Blennow K; Weiner MW; Brain; 2015 Mar; 138(Pt 3):772-83. PubMed ID: 25541191 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]